Hans Wildiers

Researcher Next ID · RN-007817

Researcher · Biochemistry, Genetics and Molecular Biology

Leuven, Belgium

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

Advanced Breast Cancer Therapies

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Frailty in Older Adults

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01323-8
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.54.8347
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70178-0
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djq526
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacological Reviews · 2004 · https://doi.org/10.1124/pr.56.4.3

No projects listed.